Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer

Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer

Background: Dipeptidyl peptidase-4 (DPP4), a cell surface protein, exhibits a crucial role in tumor biology and regulation of the immune system. We aim to study the impact of DPP4 inhibitors (DPP4i) in patients with prostate cancer (PRC), pancreatic cancer (PC) and breast cancer (BC).Methods: Using...

Full description

Bibliographic Details
Main Authors: Chintan Shah, Young-Rock Hong, Rohit Bishnoi, Azka Ali, William Paul Skelton, Long H. Dang, Jinhai Huo, Nam H. Dang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Oncology
Subjects:
DPP4 (Dipeptidyl peptidase 4) inhibitors
cancer
sitagliptin
Januvia
prostate
breast
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00405/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00405/full

Similar Items